These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 156920)

  • 21. [The properties of plasminogen activator from human blood plasma taken at sudden death].
    Markova OA
    Biokhimiia; 1983 Jan; 48(1):132-6. PubMed ID: 6219717
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acrylamide gel electrophoresis and gel filtration as methods of analysis for blood protein derivatives].
    Bosadjiev LG; Bineva I
    Dev Biol Stand; 1974; 27():44-8. PubMed ID: 4142775
    [No Abstract]   [Full Text] [Related]  

  • 23. [Essential hyperlipemia and fibrinolysis].
    Blatny J; Kojecky Z; Fischerova E
    Nouv Rev Fr Hematol; 1968; 8(2):259-61. PubMed ID: 4232374
    [No Abstract]   [Full Text] [Related]  

  • 24. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of thrombin, plasmin and plasminogen activation by amidino compounds.
    Geratz JD
    Thromb Diath Haemorrh; 1970 Jun; 23(3):486-99. PubMed ID: 4247029
    [No Abstract]   [Full Text] [Related]  

  • 27. A study on the fibrinolytic activity of cadaveric blood: isolation and characterization of plasminogen activator from cadaveric plasma after sudden death.
    Nakasono I
    Nihon Hoigaku Zasshi; 1984 Jun; 38(3):280-8. PubMed ID: 6541262
    [No Abstract]   [Full Text] [Related]  

  • 28. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood coagulation-fibrinolysis tests by a biochemical method].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1993 Jul; 41(7):743-9. PubMed ID: 8361043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolysis--a review.
    Kane KK
    Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples.
    Lewis MR; Callas PW; Jenny NS; Tracy RP
    Thromb Haemost; 2001 Dec; 86(6):1495-500. PubMed ID: 11776319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photoaffinity labeling of human plasmin and plasminogen.
    Ryan TJ
    Pharmacol Ther; 1987; 34(2):335-48. PubMed ID: 2960990
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the participation of Hageman factor in fibrinolysis.
    McDonagh RP; Ferguson JH
    Thromb Diath Haemorrh; 1970 Oct; 24(1):1-9. PubMed ID: 4249468
    [No Abstract]   [Full Text] [Related]  

  • 34. The susceptibility of plasma to activation of fibrinolysis.
    Stief TW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):123-5. PubMed ID: 8457639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of bioresolving microspheric preparations of immobilized fibrinolysin on the fibrinolysis system].
    Bessolitsyna LA; Mazaev AB; Markosian RA; Suvorov AV; Torchilin VP
    Biull Eksp Biol Med; 1980; 89(1):16-8. PubMed ID: 6445763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma fibronectin enhances fibrinolytic system in vitro.
    Gilboa N; Kaplan JE
    Thromb Haemost; 1985 Oct; 54(3):639-44. PubMed ID: 2935966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The isolation and characterization of a ternary human plasmin B-chain-streptokinase-plasminogen complex.
    Summaria L; Boreisha I; Barlow GH; Robbins KC
    Thromb Haemost; 1987 Aug; 58(2):772-7. PubMed ID: 2960030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Behavior of plasminogen in prostatic carcinoma treated with cytonal].
    Oehler D; Kätzel R; Brunner HP
    Z Urol Nephrol; 1980 Dec; 73(12):923-9. PubMed ID: 6452764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Blood of persons who died suddenly and its use in the treatment of patients with traumatic shock].
    Pafomov GA; Zhilis BG
    Probl Gematol Pereliv Krovi; 1971 Nov; 16(11):38-42. PubMed ID: 5149597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.